🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-01
Trial ID
NCT00301834
The objectives of this study are to determine the efficacy and safety of BE...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2016-02
Trial ID
NCT02411084
Treatments Being Tested
The primary objective of this study is to determine the percentage of patie...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2009-03
Trial ID
NCT00951457
Treatments Being Tested
The purpose of this study is to determine and compare the efficacy of Campa...
Status
Completed
Location
University Hospital Innsbruck
Start Date
2006-04
Trial ID
NCT00316810
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
Medizinische Universitaetsklinik I at the University of Cologne
Start Date
2003-11
Trial ID
NCT00634881
Treatments Being Tested
The purpose of this study is to determine efficacy and safety of the monocl...
Status
Completed
Location
AKH Linz
Start Date
2008-06
Trial ID
NCT00646854
This study is to assess the efficacy of Neihulizumab versus "conventional t...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2016-07
Trial ID
NCT02694770
Treatments Being Tested
This study aims to assess the short term efficacy of a combination immunoch...
Status
Completed
Location
University of Cologne
Start Date
2005-01
Trial ID
NCT00147901
Treatments Being Tested